Aino Health AB (OSTO:AINO) Total Operating Expense: kr29.35 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AINO Aino Health AB OSTO:AINO
26 GF Score
Price kr0.20
GF Value kr0.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Aino Health AB Total Operating Expense?

Aino Health AB OSTO:AINO +1.04% 26 Total Operating Expense is kr29.35 Mil as of Mar. 2026. GuruFocus rates OSTO:AINO with a GF Score™ of 26/100 and a GF Value™ of kr0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Aino Health AB's Total Operating Expense for the three months ended in Mar. 2026 was kr7.20 Mil. Aino Health AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr29.35 Mil.

Aino Health AB Total Operating Expense Related Terms

Aino Health AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Aino Health AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aino Health AB Total Operating Expense Chart

Aino Health AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.79 20.31 20.38 19.64 18.57

Aino Health AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.69 7.21 6.48 8.46 7.20
OSTO:AINO
26GF Score
Aino Health AB OSTO:AINO
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aino Health AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr29.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr29.35 Mil mean?
Aino Health AB (OSTO:AINO) has a Total Operating Expense of kr29.35 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aino Health AB and its competitors.
Is Aino Health AB's Total Operating Expense too high?
Aino Health AB's current Total Operating Expense is kr29.35 Mil. Overall, Aino Health AB has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's Total Operating Expense compare to VEEV and BTSG?
Aino Health AB's Total Operating Expense of kr29.35 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aino Health AB and its competitors. Aino Health AB's current Total Operating Expense is kr29.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.20 — trading 50% above its estimated fair value. The current Total Operating Expense is kr29.35 Mil. Aino Health AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current Total Operating Expense is kr29.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aino Health AB (OSTO:AINO) Overvalued in 2026?

Based on GuruFocus' analysis, Aino Health AB stock appears to be overvalued. The current stock price of kr0.20 is trading 50% above its estimated GF Value™ of kr0.13. GuruFocus considers Aino Health AB to be Significantly Overvalued.

Key valuation signals for OSTO:AINO:

  • Total Operating Expense: kr29.35 Mil
  • GF Value™: kr0.13 vs. price of kr0.20 (50% above fair value)
  • GF Score™: 26/100 with 4 warning signs

No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aino Health AB Business Description

Other Exchanges 50V:Germany
Address c/o Hermelin & Friends, Kungsgatan 32, Stockholm, SWE, 111 35
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
26GF Score

Get the complete analysis for OSTO:AINO

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.20
Price
kr0.13
GF Value